AbstractTetrahydrobiopterin (BH4)-responsive phenylalanine hydroxylase (PAH) deficiency is a recently recognized variant of phenylketonuria, with a probable multifactorial molecular basis. In this study we have investigated the effect of BH4 on PAH gene expression in human hepatoma. Our results show that increased BH4 levels result in an enhancement of PAH activity and PAH protein, due to longer turnover rates, while PAH mRNA levels remain unchanged. This was confirmed for mutant PAH proteins (A309V, V388M and Y414C) associated to in vivo BH4 responsiveness, validating previous studies. We can conclude that there is no effect of the cofactor on PAH gene transcription, probably being the chemical chaperone effect of BH4 stabilizing mutant PA...
More than 950 phenylalanine hydroxylase (PAH) gene variants have been identified in people with phen...
Phenylketonuria (PKU), the most frequent disorder of amino acid metabolism, is caused by mutations i...
Phenylketonuria (PKU) is an autosomal recessive metabolic disease caused by a genetic mutation that ...
AbstractTetrahydrobiopterin (BH4)-responsive phenylalanine hydroxylase (PAH) deficiency is a recentl...
AbstractThe natural cofactor of phenylalanine hydroxylase (PAH), tetrahydrobiopterin (BH4), regulate...
Treatment with tetrahydrobiopterin (BH4) is the latest therapeutic option approved for patients with...
Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency, state of the art.Spaapen LJ, Ru...
Hyperphenylalaninemias (HPAs) are genetic diseases predominantly caused by a wide range of variants ...
A subtype of phenylalanine hydroxylase (PAH) deficiency that responds to cofactor (tetrahydrobiopter...
none9noneI.Bettocchi; A.Nicoletti; F.Baronio; S.Monti; A.Rizzello; L.Baldazzi; A.Cassio; A.Pession; ...
The discovery of a pharmacological treatment for phenylketonuria (PKU) raised new questions about fu...
Phenylalanine hydroxylase (PAH) is activated by its substrate phenylalanine and inhibited by its cof...
A significant share of patients with phenylalanine hydroxylase (PAH) deficiency benefits from pharma...
AbstractPhenylalanine hydroxylase (PAH) is activated by its substrate phenylalanine and inhibited by...
Tetrahydrobiopterin (BH4) levels and GTP cyclohydrolase activity (GTP-CH) were measured in tissues f...
More than 950 phenylalanine hydroxylase (PAH) gene variants have been identified in people with phen...
Phenylketonuria (PKU), the most frequent disorder of amino acid metabolism, is caused by mutations i...
Phenylketonuria (PKU) is an autosomal recessive metabolic disease caused by a genetic mutation that ...
AbstractTetrahydrobiopterin (BH4)-responsive phenylalanine hydroxylase (PAH) deficiency is a recentl...
AbstractThe natural cofactor of phenylalanine hydroxylase (PAH), tetrahydrobiopterin (BH4), regulate...
Treatment with tetrahydrobiopterin (BH4) is the latest therapeutic option approved for patients with...
Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency, state of the art.Spaapen LJ, Ru...
Hyperphenylalaninemias (HPAs) are genetic diseases predominantly caused by a wide range of variants ...
A subtype of phenylalanine hydroxylase (PAH) deficiency that responds to cofactor (tetrahydrobiopter...
none9noneI.Bettocchi; A.Nicoletti; F.Baronio; S.Monti; A.Rizzello; L.Baldazzi; A.Cassio; A.Pession; ...
The discovery of a pharmacological treatment for phenylketonuria (PKU) raised new questions about fu...
Phenylalanine hydroxylase (PAH) is activated by its substrate phenylalanine and inhibited by its cof...
A significant share of patients with phenylalanine hydroxylase (PAH) deficiency benefits from pharma...
AbstractPhenylalanine hydroxylase (PAH) is activated by its substrate phenylalanine and inhibited by...
Tetrahydrobiopterin (BH4) levels and GTP cyclohydrolase activity (GTP-CH) were measured in tissues f...
More than 950 phenylalanine hydroxylase (PAH) gene variants have been identified in people with phen...
Phenylketonuria (PKU), the most frequent disorder of amino acid metabolism, is caused by mutations i...
Phenylketonuria (PKU) is an autosomal recessive metabolic disease caused by a genetic mutation that ...